← Back to contracts

DoW Breast Cancer, Transformative Breast Cancer Consortium Award

US · MD Dept › of the Army -- U › S › Army Medical Research Acquisition Activity (USAMRAA) grant open #HT942526BCRPTBCCA

Response due Sep 30, 2026 · 00:00 UTC

Summary

The Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA) is soliciting applications for the Transformative Breast Cancer Consortium Award under the Department of Defense (DoD) Breast Cancer Research Program. This is a federal grant opportunity focused on breast cancer research. The award targets transformative, high-impact consortium-based research efforts. The opportunity was posted on Grants.gov with a synopsis document type, suggesting a forthcoming or active funding announcement.

What they want

Applicants are invited to submit proposals for consortium-based, transformative breast cancer research under the DoD Breast Cancer Research Program (BCRP). The award mechanism is a consortium structure, implying multi-institutional collaboration. No further scope details (specific research focus areas, award amounts, or deliverables) are provided in the synopsis.

How they evaluate

Submission: Grants.gov electronic submission portal

Risks & flags

Synopsis only — full funding opportunity announcement (FOA) details not yet available; scope, evaluation criteria, and eligibility requirements are unknown
Consortium award structure may favor established multi-institutional research networks with prior DoD BCRP relationships
No dollar value or award ceiling disclosed, making cost competitiveness difficult to assess

Market context

inferred from NAICS

Professional, Scientific & Technical Services

NAICS 541711

US market size: $2.0T
Typical award: $25K – $50M

Typical buyers

All federal civilianDoDStates

Commonly required

8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

DoW Breast Cancer, Transformative Breast C…

Due Sep 30

Onboard ↗